img

Global Genetic Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Genetic Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Gene vaccine refers to DNA vaccine, the gene encoding exogenous antigen is inserted into the plasmid containing eukaryotic expression system, and then the plasmid is directly introduced into the human or animal body, allowing it to express antigen protein in host cells and induce the immune response of the body.
The global Genetic Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Genetic Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Genetic Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Genetic Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Genetic Vaccine include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Genetic Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Genetic Vaccine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Genetic Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Genetic Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
By Type
Recombinant Protein Vaccine
Gene-Based Vaccine
By Application
Human
Animal
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Genetic Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Genetic Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetic Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Genetic Vaccine Definition
1.2 Market by Type
1.2.1 Global Genetic Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Market Segment by Application
1.3.1 Global Genetic Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Human
1.3.3 Animal
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Genetic Vaccine Sales
2.1 Global Genetic Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Genetic Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Genetic Vaccine Revenue by Region
2.3.1 Global Genetic Vaccine Revenue by Region (2018-2024)
2.3.2 Global Genetic Vaccine Revenue by Region (2024-2034)
2.4 Global Genetic Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Genetic Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Genetic Vaccine Sales Quantity by Region
2.6.1 Global Genetic Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Genetic Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Genetic Vaccine Sales Quantity by Manufacturers
3.1.1 Global Genetic Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Genetic Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Genetic Vaccine Sales in 2022
3.2 Global Genetic Vaccine Revenue by Manufacturers
3.2.1 Global Genetic Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Genetic Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Genetic Vaccine Revenue in 2022
3.3 Global Genetic Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Genetic Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Genetic Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Genetic Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Genetic Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Genetic Vaccine Sales Quantity by Type
4.1.1 Global Genetic Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Genetic Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Genetic Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Genetic Vaccine Revenue by Type
4.2.1 Global Genetic Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Genetic Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Genetic Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Genetic Vaccine Price by Type
4.3.1 Global Genetic Vaccine Price by Type (2018-2024)
4.3.2 Global Genetic Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Genetic Vaccine Sales Quantity by Application
5.1.1 Global Genetic Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Genetic Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Genetic Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Genetic Vaccine Revenue by Application
5.2.1 Global Genetic Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Genetic Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Genetic Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Genetic Vaccine Price by Application
5.3.1 Global Genetic Vaccine Price by Application (2018-2024)
5.3.2 Global Genetic Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Genetic Vaccine Sales by Company
6.1.1 North America Genetic Vaccine Revenue by Company (2018-2024)
6.1.2 North America Genetic Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Genetic Vaccine Market Size by Type
6.2.1 North America Genetic Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Genetic Vaccine Revenue by Type (2018-2034)
6.3 North America Genetic Vaccine Market Size by Application
6.3.1 North America Genetic Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Genetic Vaccine Revenue by Application (2018-2034)
6.4 North America Genetic Vaccine Market Size by Country
6.4.1 North America Genetic Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Genetic Vaccine Revenue by Country (2018-2034)
6.4.3 North America Genetic Vaccine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Genetic Vaccine Sales by Company
7.1.1 Europe Genetic Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Genetic Vaccine Revenue by Company (2018-2024)
7.2 Europe Genetic Vaccine Market Size by Type
7.2.1 Europe Genetic Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Genetic Vaccine Revenue by Type (2018-2034)
7.3 Europe Genetic Vaccine Market Size by Application
7.3.1 Europe Genetic Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Genetic Vaccine Revenue by Application (2018-2034)
7.4 Europe Genetic Vaccine Market Size by Country
7.4.1 Europe Genetic Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Genetic Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Genetic Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Genetic Vaccine Sales by Company
8.1.1 China Genetic Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Genetic Vaccine Revenue by Company (2018-2024)
8.2 China Genetic Vaccine Market Size by Type
8.2.1 China Genetic Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Genetic Vaccine Revenue by Type (2018-2034)
8.3 China Genetic Vaccine Market Size by Application
8.3.1 China Genetic Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Genetic Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Genetic Vaccine Sales by Company
9.1.1 APAC Genetic Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Genetic Vaccine Revenue by Company (2018-2024)
9.2 APAC Genetic Vaccine Market Size by Type
9.2.1 APAC Genetic Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Genetic Vaccine Revenue by Type (2018-2034)
9.3 APAC Genetic Vaccine Market Size by Application
9.3.1 APAC Genetic Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Genetic Vaccine Revenue by Application (2018-2034)
9.4 APAC Genetic Vaccine Market Size by Region
9.4.1 APAC Genetic Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Genetic Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Genetic Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Genetic Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Genetic Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Genetic Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Genetic Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Genetic Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Genetic Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Genetic Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Genetic Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Genetic Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Genetic Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck Genetic Vaccine Products and Services
11.1.5 Merck Genetic Vaccine SWOT Analysis
11.1.6 Merck Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Genetic Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 GSK Genetic Vaccine Products and Services
11.2.5 GSK Genetic Vaccine SWOT Analysis
11.2.6 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Genetic Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Sanofi Genetic Vaccine Products and Services
11.3.5 Sanofi Genetic Vaccine SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 Zoties
11.4.1 Zoties Company Information
11.4.2 Zoties Overview
11.4.3 Zoties Genetic Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Zoties Genetic Vaccine Products and Services
11.4.5 Zoties Genetic Vaccine SWOT Analysis
11.4.6 Zoties Recent Developments
11.5 Elanco
11.5.1 Elanco Company Information
11.5.2 Elanco Overview
11.5.3 Elanco Genetic Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Elanco Genetic Vaccine Products and Services
11.5.5 Elanco Genetic Vaccine SWOT Analysis
11.5.6 Elanco Recent Developments
11.6 Boehringer-Ingelheim
11.6.1 Boehringer-Ingelheim Company Information
11.6.2 Boehringer-Ingelheim Overview
11.6.3 Boehringer-Ingelheim Genetic Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Boehringer-Ingelheim Genetic Vaccine Products and Services
11.6.5 Boehringer-Ingelheim Genetic Vaccine SWOT Analysis
11.6.6 Boehringer-Ingelheim Recent Developments
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Company Information
11.7.2 Indian Immunologicals Overview
11.7.3 Indian Immunologicals Genetic Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Indian Immunologicals Genetic Vaccine Products and Services
11.7.5 Indian Immunologicals Genetic Vaccine SWOT Analysis
11.7.6 Indian Immunologicals Recent Developments
11.8 Plumbline Life Sciences
11.8.1 Plumbline Life Sciences Company Information
11.8.2 Plumbline Life Sciences Overview
11.8.3 Plumbline Life Sciences Genetic Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Plumbline Life Sciences Genetic Vaccine Products and Services
11.8.5 Plumbline Life Sciences Genetic Vaccine SWOT Analysis
11.8.6 Plumbline Life Sciences Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Genetic Vaccine Value Chain Analysis
12.2 Genetic Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Genetic Vaccine Production Mode & Process
12.4 Genetic Vaccine Sales and Marketing
12.4.1 Genetic Vaccine Sales Channels
12.4.2 Genetic Vaccine Distributors
12.5 Genetic Vaccine Customers
13 Market Dynamics
13.1 Genetic Vaccine Industry Trends
13.2 Genetic Vaccine Market Drivers
13.3 Genetic Vaccine Market Challenges
13.4 Genetic Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Genetic Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Recombinant Protein Vaccine
Table 3. Major Manufacturers of Gene-Based Vaccine
Table 4. Global Genetic Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Genetic Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Genetic Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Genetic Vaccine Revenue Market Share by Region (2018-2024)
Table 8. Global Genetic Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Genetic Vaccine Revenue Market Share by Region (2024-2034)
Table 10. Global Genetic Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Genetic Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Genetic Vaccine Sales Market Share by Region (2018-2024)
Table 13. Global Genetic Vaccine Sales by Region (2024-2034) & (K Units)
Table 14. Global Genetic Vaccine Sales Market Share by Region (2024-2034)
Table 15. Global Genetic Vaccine Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Genetic Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Genetic Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Genetic Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Genetic Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Genetic Vaccine, Industry Ranking, 2021 VS 2022
Table 21. Global Genetic Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Genetic Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genetic Vaccine as of 2022)
Table 23. Global Key Manufacturers of Genetic Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Genetic Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Genetic Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Genetic Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Genetic Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Genetic Vaccine Sales Quantity Share by Type (2018-2024)
Table 30. Global Genetic Vaccine Sales Quantity Share by Type (2024-2034)
Table 31. Global Genetic Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Genetic Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Genetic Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Genetic Vaccine Revenue Share by Type (2024-2034)
Table 35. Genetic Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Genetic Vaccine Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Genetic Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Genetic Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Genetic Vaccine Sales Quantity Share by Application (2018-2024)
Table 40. Global Genetic Vaccine Sales Quantity Share by Application (2024-2034)
Table 41. Global Genetic Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Genetic Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Genetic Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Genetic Vaccine Revenue Share by Application (2024-2034)
Table 45. Genetic Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Genetic Vaccine Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Genetic Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Genetic Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Genetic Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Genetic Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Genetic Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Genetic Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Genetic Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Genetic Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Genetic Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Genetic Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Genetic Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Genetic Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Genetic Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Genetic Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Genetic Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Genetic Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Genetic Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Genetic Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Genetic Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Genetic Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Genetic Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Genetic Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Genetic Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Genetic Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Genetic Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Genetic Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Genetic Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Genetic Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Genetic Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Genetic Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Genetic Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Genetic Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Genetic Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Genetic Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Genetic Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Genetic Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Genetic Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Genetic Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Genetic Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Genetic Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Genetic Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Genetic Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Genetic Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Genetic Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Genetic Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Genetic Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Genetic Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Genetic Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Genetic Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Genetic Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Genetic Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Genetic Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Genetic Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Genetic Vaccine Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Genetic Vaccine Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Genetic Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Genetic Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Genetic Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Genetic Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Genetic Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Genetic Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Genetic Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Genetic Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Merck Company Information
Table 118. Merck Description and Overview
Table 119. Merck Genetic Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Merck Genetic Vaccine Product and Services
Table 121. Merck Genetic Vaccine SWOT Analysis
Table 122. Merck Recent Developments
Table 123. GSK Company Information
Table 124. GSK Description and Overview
Table 125. GSK Genetic Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. GSK Genetic Vaccine Product and Services
Table 127. GSK Genetic Vaccine SWOT Analysis
Table 128. GSK Recent Developments
Table 129. Sanofi Company Information
Table 130. Sanofi Description and Overview
Table 131. Sanofi Genetic Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Sanofi Genetic Vaccine Product and Services
Table 133. Sanofi Genetic Vaccine SWOT Analysis
Table 134. Sanofi Recent Developments
Table 135. Zoties Company Information
Table 136. Zoties Description and Overview
Table 137. Zoties Genetic Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Zoties Genetic Vaccine Product and Services
Table 139. Zoties Genetic Vaccine SWOT Analysis
Table 140. Zoties Recent Developments
Table 141. Elanco Company Information
Table 142. Elanco Description and Overview
Table 143. Elanco Genetic Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. Elanco Genetic Vaccine Product and Services
Table 145. Elanco Genetic Vaccine SWOT Analysis
Table 146. Elanco Recent Developments
Table 147. Boehringer-Ingelheim Company Information
Table 148. Boehringer-Ingelheim Description and Overview
Table 149. Boehringer-Ingelheim Genetic Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. Boehringer-Ingelheim Genetic Vaccine Product and Services
Table 151. Boehringer-Ingelheim Genetic Vaccine SWOT Analysis
Table 152. Boehringer-Ingelheim Recent Developments
Table 153. Indian Immunologicals Company Information
Table 154. Indian Immunologicals Description and Overview
Table 155. Indian Immunologicals Genetic Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. Indian Immunologicals Genetic Vaccine Product and Services
Table 157. Indian Immunologicals Genetic Vaccine SWOT Analysis
Table 158. Indian Immunologicals Recent Developments
Table 159. Plumbline Life Sciences Company Information
Table 160. Plumbline Life Sciences Description and Overview
Table 161. Plumbline Life Sciences Genetic Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 162. Plumbline Life Sciences Genetic Vaccine Product and Services
Table 163. Plumbline Life Sciences Genetic Vaccine SWOT Analysis
Table 164. Plumbline Life Sciences Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Genetic Vaccine Distributors List
Table 168. Genetic Vaccine Customers List
Table 169. Genetic Vaccine Market Trends
Table 170. Genetic Vaccine Market Drivers
Table 171. Genetic Vaccine Market Challenges
Table 172. Genetic Vaccine Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Genetic Vaccine Product Picture
Figure 2. Global Genetic Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Genetic Vaccine Market Share by Type in 2022 & 2034
Figure 4. Recombinant Protein Vaccine Product Picture
Figure 5. Gene-Based Vaccine Product Picture
Figure 6. Global Genetic Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Genetic Vaccine Market Share by Application in 2022 & 2034
Figure 8. Human
Figure 9. Animal
Figure 10. Genetic Vaccine Report Years Considered
Figure 11. Global Genetic Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Genetic Vaccine Revenue 2018-2034 (US$ Million)
Figure 13. Global Genetic Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Genetic Vaccine Sales Quantity 2018-2034 (K Units)
Figure 15. Global Genetic Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 16. Global Genetic Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Genetic Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Genetic Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Genetic Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Genetic Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Genetic Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Genetic Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Genetic Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Genetic Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Genetic Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Genetic Vaccine Sales Quantity in 2022
Figure 28. The Top 10 and Top 5 Players Market Share by Genetic Vaccine Revenue in 2022
Figure 29. Genetic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Genetic Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Genetic Vaccine Revenue Market Share by Type (2018-2034)
Figure 32. Global Genetic Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Genetic Vaccine Revenue Market Share by Application (2018-2034)
Figure 34. North America Genetic Vaccine Revenue Market Share by Company in 2022
Figure 35. North America Genetic Vaccine Sales Quantity Market Share by Company in 2022
Figure 36. North America Genetic Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Genetic Vaccine Revenue Market Share by Type (2018-2034)
Figure 38. North America Genetic Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Genetic Vaccine Revenue Market Share by Application (2018-2034)
Figure 40. North America Genetic Vaccine Revenue Share by Country (2018-2034)
Figure 41. North America Genetic Vaccine Sales Quantity Share by Country (2018-2034)
Figure 42. U.S. Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Genetic Vaccine Sales Quantity Market Share by Company in 2022
Figure 45. Europe Genetic Vaccine Revenue Market Share by Company in 2022
Figure 46. Europe Genetic Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Genetic Vaccine Revenue Market Share by Type (2018-2034)
Figure 48. Europe Genetic Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Genetic Vaccine Revenue Market Share by Application (2018-2034)
Figure 50. Europe Genetic Vaccine Revenue Share by Country (2018-2034)
Figure 51. Europe Genetic Vaccine Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 53. France Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. China Genetic Vaccine Sales Quantity Market Share by Company in 2022
Figure 58. China Genetic Vaccine Revenue Market Share by Company in 2022
Figure 59. China Genetic Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Genetic Vaccine Revenue Market Share by Type (2018-2034)
Figure 61. China Genetic Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Genetic Vaccine Revenue Market Share by Application (2018-2034)
Figure 63. APAC Genetic Vaccine Sales Quantity Market Share by Company in 2022
Figure 64. APAC Genetic Vaccine Revenue Market Share by Company in 2022
Figure 65. APAC Genetic Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Genetic Vaccine Revenue Market Share by Type (2018-2034)
Figure 67. APAC Genetic Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Genetic Vaccine Revenue Market Share by Application (2018-2034)
Figure 69. APAC Genetic Vaccine Revenue Share by Region (2018-2034)
Figure 70. APAC Genetic Vaccine Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 75. India Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity Market Share by Company in 2022
Figure 77. Middle East, Africa and Latin America Genetic Vaccine Revenue Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Genetic Vaccine Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Genetic Vaccine Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Genetic Vaccine Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Genetic Vaccine Revenue Share by Country (2018-2034)
Figure 84. Brazil Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Genetic Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. Genetic Vaccine Value Chain
Figure 90. Genetic Vaccine Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed